Armin Ghobadi

3 ta ish

Washington University in St. Louis

1. Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma

   Sattva S. Neelapu, Frederick L. Locke, Nancy L. Bartlett +37

   Maqola20174 iqtibos

   ABIABI:AkademIndex/2026.other.296830

2. Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma

   Frederick L. Locke, David B. Miklos, Caron A. Jacobson +28

   Maqola20212 iqtibos

   ABIABI:AkademIndex/2026.other.319265

3. Medicare Utilization and Cost Trends for CAR T Cell Therapies Across Settings of Care in the Treatment of Diffuse Large B-Cell Lymphoma

   James J. Wu, Armin Ghobadi, Richard T. Maziarz +6

   Maqola20242 iqtibos

   ABIABI:AkademIndex/2026.other.340920